Table I.

Association of WAVE3 expression with the clinicopathological characteristics of the patients with pancreatic cancer.

Characteristics	WAVE3 expression		P-valuea
	High	Low
Sex			0.2535
Male	31	24
Female	22	10
Ageb			0.2555
≥62	30	15
<62	23	19
Lymphatic metastasis			0.0004
Negative	27	30
Positive	26	4
Distant metastasis			0.2775
Negative	50	34
Positive	3	0
Clinical stage			0.7469
I	9	9
II	40	23	0.2833
T2a	17	13
T2b	23	10
III	3	2
IV	1	0
Differentiation			<0.0001
Poor	25	2
Moderate	28	25
Well	0	7
Pre-surgery level of CA19-9c			<0.0001
High	49	16
Low	4	18
Pre-surgery level of CA125d			0.5564
High	9	4
Low	44	30
Pre-surgery level of CEAe			0.7736
High	10	5
Low	43	29
Smoking history			0.4193
Yes	15	7
No	38	27
History of alcohol consumption			0.5747
Yes	12	6
No	41	28

^aDifferences between categorical variables were compared using the Chi-square test, and when the number of variables was <5, Fisher’s exact test was used to detect the difference;

^bage, the median age of the pancreatic cancer patients was 62;

^cCA19-9>37 U/ml was classified as high, and CA19-9≤37 U/ml was classified as low;

^dCA125>35 U/ml was classified as high, and CA125≤35 U/ml was classified as low;

^eCEA>5 ng/ml was classified as high, and CEA≤5 ng/ml was classified as low.